Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
67.35B | 61.91B | 65.07B | 60.49B | 42.39B | 56.66B | Gross Profit |
4.84B | 4.84B | 4.18B | 4.05B | 4.15B | 3.85B | EBIT |
671.00M | 913.00M | 338.00M | 517.00M | 655.00M | 341.00M | EBITDA |
1.63B | 1.92B | 1.59B | 1.22B | 1.33B | 900.00M | Net Income Common Stockholders |
420.00M | 607.00M | 408.00M | 2.04B | 632.00M | 565.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.30B | 3.48B | 2.75B | 4.04B | 4.61B | 3.52B | Total Assets |
22.22B | 19.12B | 17.98B | 20.00B | 18.01B | 18.12B | Total Debt |
1.03B | 30.00M | 30.00M | 0.00 | 0.00 | 0.00 | Net Debt |
-3.27B | -3.40B | -2.71B | -4.04B | -4.61B | -3.52B | Total Liabilities |
12.83B | 9.62B | 8.67B | 10.23B | 8.02B | 8.58B | Stockholders Equity |
9.39B | 9.50B | 9.31B | 9.77B | 9.99B | 9.54B |
Cash Flow | Free Cash Flow | ||||
698.00M | 1.09B | 65.00M | -445.00M | 623.00M | 70.00M | Operating Cash Flow |
1.87B | 1.96B | 870.00M | 192.00M | 2.41B | 586.00M | Investing Cash Flow |
-1.05B | -767.00M | -1.45B | 1.53B | -1.24B | 70.00M | Financing Cash Flow |
373.00M | -462.00M | -750.00M | -2.30B | -78.00M | -348.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥11.32B | 10.93 | 3.73% | 7.80% | -20.52% | ||
73 Outperform | ¥19.24B | 26.76 | 5.05% | 13.42% | 19.33% | ||
67 Neutral | ¥10.65B | 20.96 | 6.44% | 9.77% | -46.77% | ||
62 Neutral | $1.85T | 8.57 | -0.17% | 3.43% | -5.09% | 3.44% | |
61 Neutral | $1.20T | 11.96 | 5.72% | 4.09% | 6.32% | -49.47% | |
56 Neutral | $7.25B | 3.36 | -3.66% | 5.65% | 0.66% | -50.71% | |
54 Neutral | €21.50B | 21.43 | -6.69% | 4.23% | 17.09% | -90.47% |